| 2024 | 2023 | |||
|---|---|---|---|---|
| Gross margin | 34,9 k € | -31.1% | 50,6 k € | |
| EBITDA | 33,3 k € | +138.1% | 14,0 k € | |
| Operating profit | 27,5 k € | +234.6% | 8,2 k € | |
| Profit/loss | 18,1 k € | +264.7% | 5,0 k € | |
| Equity | 25,0 k € | +259.8% | 7,0 k € | |
| Total assets | 54,1 k € | +25.1% | 43,3 k € | |
| Cash | 19,6 k € | +301.9% | 4,9 k € | |
| Debts | 29,1 k € | -19.8% | 36,3 k € | |
Private limited company · Manage · incorporated on 12/01/2023
Private limited company profitable and well capitalised. Cash position rising (+301.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
FERLIN NGOUGNI MEDICAL CONSULTING is a Private limited company incorporated in 2023. Its main activity is: Other human health activities. Its registered office is in Manage.